Laura Brege, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 4,500 shares at $24.87 ($112K) on 2023-06-12, disclosed to the SEC on 2023-06-14.
Scheduled sale ($112k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |
| PCRX | SELL | 2023-04-05 | $285K | — | Filing → |